251 related articles for article (PubMed ID: 29175141)
1. Large neutral amino acid supplementation as an alternative to the phenylalanine-restricted diet in adults with phenylketonuria: evidence from adult Pah-enu2 mice.
van Vliet D; van der Goot E; Bruinenberg VM; van Faassen M; de Blaauw P; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
J Nutr Biochem; 2018 Mar; 53():20-27. PubMed ID: 29175141
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model.
van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Pascucci T; Puglisi-Allegra S; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Am J Clin Nutr; 2016 Nov; 104(5):1292-1300. PubMed ID: 27655443
[TBL] [Abstract][Full Text] [Related]
3. The Benefit of Large Neutral Amino Acid Supplementation to a Liberalized Phenylalanine-Restricted Diet in Adult Phenylketonuria Patients: Evidence from Adult
van Vliet D; van der Goot E; van Ginkel WG; van Faassen MHJR; de Blaauw P; Kema IP; Martinez A; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31546852
[TBL] [Abstract][Full Text] [Related]
4. The increasing importance of LNAA supplementation in phenylketonuria at higher plasma phenylalanine concentrations.
van Vliet D; van der Goot E; van Ginkel WG; van Faassen HJR; de Blaauw P; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Mol Genet Metab; 2022 Jan; 135(1):27-34. PubMed ID: 34974973
[TBL] [Abstract][Full Text] [Related]
5. Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice.
van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Kema IP; Heiner-Fokkema MR; van Anholt RD; van der Zee EA; van Spronsen FJ
PLoS One; 2015; 10(12):e0143833. PubMed ID: 26624009
[TBL] [Abstract][Full Text] [Related]
6. Large Neutral Amino Acids (LNAAs) Supplementation Improves Neuropsychological Performances in Adult Patients with Phenylketonuria.
Scala I; Riccio MP; Marino M; Bravaccio C; Parenti G; Strisciuglio P
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326614
[TBL] [Abstract][Full Text] [Related]
7. Future role of large neutral amino acids in transport of phenylalanine into the brain.
Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
[TBL] [Abstract][Full Text] [Related]
8. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
[TBL] [Abstract][Full Text] [Related]
9. The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria.
Burlina AP; Cazzorla C; Massa P; Loro C; Gueraldi D; Burlina AB
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32674279
[TBL] [Abstract][Full Text] [Related]
10. Large neutral amino acids in the treatment of PKU: from theory to practice.
van Spronsen FJ; de Groot MJ; Hoeksma M; Reijngoud DJ; van Rijn M
J Inherit Metab Dis; 2010 Dec; 33(6):671-6. PubMed ID: 20976625
[TBL] [Abstract][Full Text] [Related]
11. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.
Vogel KR; Arning E; Wasek BL; Bottiglieri T; Gibson KM
Mol Genet Metab; 2013; 110 Suppl(0):S71-8. PubMed ID: 23999161
[TBL] [Abstract][Full Text] [Related]
13. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
Moats RA; Moseley KD; Koch R; Nelson M
Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
[TBL] [Abstract][Full Text] [Related]
14. Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?
van Spronsen FJ; Hoeksma M; Reijngoud DJ
J Inherit Metab Dis; 2009 Feb; 32(1):46-51. PubMed ID: 19191004
[TBL] [Abstract][Full Text] [Related]
15. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.
Pietz J; Kreis R; Rupp A; Mayatepek E; Rating D; Boesch C; Bremer HJ
J Clin Invest; 1999 Apr; 103(8):1169-78. PubMed ID: 10207169
[TBL] [Abstract][Full Text] [Related]
16. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
[TBL] [Abstract][Full Text] [Related]
17. Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice.
van Ginkel WG; van Vliet D; van der Goot E; Faassen MHJR; Vogel A; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31623189
[TBL] [Abstract][Full Text] [Related]
18. Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria.
MacDonald A; Singh RH; Rocha JC; van Spronsen FJ
Nutr Res Rev; 2019 Jun; 32(1):70-78. PubMed ID: 30284526
[TBL] [Abstract][Full Text] [Related]
19. Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.
Ney DM; Hull AK; van Calcar SC; Liu X; Etzel MR
J Nutr; 2008 Feb; 138(2):316-22. PubMed ID: 18203898
[TBL] [Abstract][Full Text] [Related]
20. Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.
Winn SR; Scherer T; Thöny B; Ying M; Martinez A; Weber S; Raber J; Harding CO
Mol Genet Metab; 2018 Jan; 123(1):6-20. PubMed ID: 29331172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
